BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 25, 2004
View Archived Issues
New polymeric cytotoxic agents developed by Sankyo scientists
Read More
Novel antitumor protein kinase inhibitors under study at Abbott
Read More
Novel SGLT inhibitors prepared and tested by Yamanouchi and Kotobuki scientists
Read More
Novartis claims aldosterone synthase inhibitors and their use
Read More
Novel antifungal agents isolated and tested at Meiji Seika
Read More
Novel tachykinin NK1 antagonists covered by Tanabe Seiyaku patent
Read More
Exercise and metformin improve cardiovascular parameters in HIV-infected patients
Read More
Safety and pharmacokinetics of a human monoclonal antibody for anthrax
Read More
Improved diagnosis of stenosis achieved with the contrast agent MS-325
Read More
Diagnostic benefits of the contrast agent SHL-643A in magnetic resonance imaging
Read More
Novel selective TGF-beta inhibitor by GlaxoSmithKline
Read More
PARP inhibitor HO-3089 demonstrates both cardioprotective and antithrombotic potential
Read More
Phase IIa results for diabetic complication drug AS-3201
Read More
Cangene to evaluate WinRho SDF for dengue hemorrhagic fever
Read More
Enrollment completed in phase II study of SPI-0211 for IBS
Read More
NM-100061 produces positive results in early ejaculation study
Read More
Astex Technology joins BRAF drug discovery collaboration
Read More
Aplidin enters phase I for pediatric solid tumors and hematological malignancies
Read More
Siga completes successful smallpox vaccine study
Read More
Pharmacopeia extends and expands research collaboration with Celgene
Read More
OraQuick Rapid HIV-1/2 Antibody Test receives FDA approval
Read More
Protein Mechanics and Aventis enter MMP inhibitor research collaboration
Read More
SBIR grant supports development of novel anti-HIV therapeutics at Aphios
Read More
European filing for Antegren for MS planned for summer
Read More
Proteome Sciences licenses biomarkers for Alzheimer's disease
Read More
HuMax-CD4 receives fast track designation for cutaneous T-cell lymphoma
Read More
Pharmexa shifts strategic focus from research to development
Read More
Ligand reports progress during 2003
Read More
Antidepressant and anxiolytic potential of MGS-0039, a potent, selective group II mGluR antagonist
Read More
Chronic administration of (-)-BPAP may be effective against stress disorders
Read More
Potent neuroprotective effects of FR-210575, a powerful free radical scavenger
Read More